0
0
As autumn 2025 unfolds, the UK faces a rise in Covid-19 cases driven by two new variants, XFG—nicknamed Stratus—and NB.1.8.1, called Nimbus. These variants have now become the predominant strains circulating across the country, prompting renewed public health attention. Although these variants are more transmissible, current evidence suggests they do not cause more severe illness than previous Covid strains, nor do they diminish the protective effects of existing vaccines. However, their emergence underscores the ongoing need for vigilance and vaccination, especially ahead of the winter season.
Emergence and Characteristics of Nimbus and Stratus Variants
The Stratus variant (XFG) is a recombinant strain derived from two Omicron subvariants, first detected in Southeast Asia in early 2025 before spreading globally. It now accounts for over 60% of Covid cases worldwide and nearly 70% of cases in the UK. The World Health Organization (WHO) classifies XFG as a “variant under monitoring,” with its growth attributed to increased transmissibility partly due to immune evasion capabilities. Despite spreading efficiently, no increase in disease severity or mortality rates has been observed.
Parallel to Stratus, the Nimbus variant (NB.1.8.1) also emerged early in 2025 and is similarly classified by WHO as a variant under monitoring. It is rapidly gaining ground, especially in Asia, the US, and the UK. Nimbus presents a distinctive symptom profile that some patients describe as a “razor blade” sore throat—a severe, sharp throat pain different from typical respiratory infections. Gastrointestinal symptoms like nausea are also reported with Nimbus infections. Yet, there is no current evidence suggesting it causes more severe illness than earlier variants.
Clinical Presentation and Public Health Impact
Both variants exhibit overlapping symptoms typical of Covid-19, including cough, fever, headache, nasal congestion or runny nose, fatigue, and sometimes loss of taste or smell. A hoarse or raspy voice, particularly with Stratus, and the intense sore throat with Nimbus, have been highlighted as unusual but not definitive indicators.
Public health bodies including the UK Health Security Agency (UKHSA) report a 7.6% weekly increase in Covid cases in England as of early September 2025, with hospital admissions trending upward. Notably, the highest rates of admission occur among elderly populations over 75 years. ICU admission rates remain low, suggesting most cases are mild to moderate. Despite increased case numbers, experts emphasize that neither variant appears to increase the risk of severe disease or death significantly.
Expert Commentary and Vaccine Efficacy
Dr. Alex Allen, Consultant Epidemiologist at UKHSA, states, “Based on current data, there is no evidence to suggest these variants cause more severe disease or reduce vaccine efficacy.” Existing vaccines remain effective in preventing severe outcomes, particularly for vulnerable groups. The UKHSA continues to recommend vaccinations, highlighting that over-75s are entitled to free Covid vaccines on the NHS. Vaccination against other respiratory illnesses like influenza and RSV is also urged to reduce the combined burden during winter.
Professor Hunter, a virologist commenting on Stratus, notes that “Stratus’s growth advantage is moderate compared to earlier variants like Omicron, so while it contributes to increased cases, it is not the sole driver.” He underscores the importance of differentiating Covid symptoms from other viral infections such as adenoviruses, which can cause similar symptoms like hoarseness.
Practical Guidance for the Public
If symptoms such as a severe sore throat, hoarseness, fever, or cough develop, it is prudent to consider the possibility of Covid infection and act to minimize spread, especially to vulnerable individuals. The UKHSA advises staying home if possible, wearing face coverings in public if leaving home, and practicing good hand hygiene. For sore throats, staying hydrated and using remedies like a teaspoon of honey may provide relief.
Access to Covid testing has become limited, with free tests largely phased out, but rapid antigen tests remain available for purchase at pharmacies. Private clinics also offer vaccinations, though the cost can vary.
Counterpoints and Limitations
Despite emerging data, diagnosing Covid infections based solely on the presence of symptoms like hoarseness or razor blade throat is challenging due to symptom overlap with common colds and other respiratory viruses. Laboratory testing remains essential for accurate identification.
Reinfections remain possible even in vaccinated individuals or those recently recovered from Covid, generally causing milder disease but still facilitating transmission. Continued genomic surveillance is crucial to detect any future changes in virus behavior or vaccine effectiveness.
Conclusion
The rise in Covid cases fueled by Stratus and Nimbus variants signals that SARS-CoV-2 continues to evolve as it circulates globally. While these variants do not currently pose a greater threat in terms of severity or vaccine resistance, awareness and preventive measures remain vital. Vaccination, personal hygiene, and responsible behavior can help mitigate the impact of this new phase of the pandemic.
Medical Disclaimer: This article is for informational purposes only and should not be considered medical advice. Always consult with qualified healthcare professionals before making any health-related decisions or changes to your treatment plan. The information presented here is based on current research and expert opinions, which may evolve as new evidence emerges.
References
